Skip to main content
Top
Published in: Rheumatology International 9/2010

01-07-2010 | Original Article

Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population

Authors: Deepali Gambhir, Able Lawrence, Amita Aggarwal, Ramnath Misra, Sudhir Kumar Mandal, Sita Naik

Published in: Rheumatology International | Issue 9/2010

Login to get access

Abstract

Rheumatoid arthritis is a chronic autoimmune disorder associated with altered expression of pro- and anti-inflammatory cytokines in the affected tissues. The aim of this study was to investigate the association between promoter polymorphisms of TNFα and IL-10 gene with susceptibility, age of disease onset and disease severity in North Indian patients with rheumatoid arthritis (RA). SNPs at position −308 and −863 of TNF gene and −819/−592 and −1082 position of IL-10 gene were determined in 222 patients and 208 healthy controls using RFLP or ARMS method. Polymorphism TNF −308A was less prevalent among the patients (1.7%) than controls (4.9%; p = 0.01, OR: 0.32, 95% CI: 0.13–0.76). Among female patients, IL-10 −592A allele associated with higher baseline disease activity scores (5.77 ± 1.99) than −592C (5.57 ± 1.19; p = 0.04). Female patients carrying allele A of TNFα −863 had earlier age of onset of RA (33.99 ± 9.6 years) than those with allele C (36.15 ± 11.21 years; p = 0.043). In conclusion, allele A at TNFα −308 locus provides protection against RA in North Indian population while another TNF allele A at −863 position had weak association with earlier onset of disease in female patients. On the other hand promoter polymorphisms of IL-10 did not affect susceptibility but polymorphism at −819/−592A was associated with higher disease activity scores at baseline.
Literature
1.
go back to reference Kirkham BW, Lassere MN, Edmonds JP et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in Rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed Kirkham BW, Lassere MN, Edmonds JP et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in Rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed
2.
go back to reference Paramalingam SS, Thumboo J, Vasoo S et al (2007) In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99 Paramalingam SS, Thumboo J, Vasoo S et al (2007) In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99
3.
go back to reference Brennan FM, Maini RN, Feldmann M (1992) TNF alpha-A pivotal role in rheumatoid arthritis. Br J Rheumatol 31:293–298CrossRefPubMed Brennan FM, Maini RN, Feldmann M (1992) TNF alpha-A pivotal role in rheumatoid arthritis. Br J Rheumatol 31:293–298CrossRefPubMed
4.
go back to reference Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumor necrosis factor: a predictive model of arthritis. EMBO J 10:4025–4031PubMed Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumor necrosis factor: a predictive model of arthritis. EMBO J 10:4025–4031PubMed
5.
go back to reference Elliott MJ, Maini RN, Feldmann M et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681–1690CrossRefPubMed Elliott MJ, Maini RN, Feldmann M et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681–1690CrossRefPubMed
6.
go back to reference Persson S, Mikulowska A, Narula S et al (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44(6):607–614CrossRefPubMed Persson S, Mikulowska A, Narula S et al (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44(6):607–614CrossRefPubMed
7.
go back to reference Jorgensen C, Apparailly F, Canovas F et al (1999) Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 42(4):678–685CrossRefPubMed Jorgensen C, Apparailly F, Canovas F et al (1999) Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 42(4):678–685CrossRefPubMed
8.
9.
go back to reference Trinchieri G (1997) Cytokines acting on or secreted by macrophages during intracellular infection. Curr Opin Immunol 9:17–23CrossRefPubMed Trinchieri G (1997) Cytokines acting on or secreted by macrophages during intracellular infection. Curr Opin Immunol 9:17–23CrossRefPubMed
10.
go back to reference Dickensheets H, Freeman SL, Smith M et al (1997) Interleukin 10 upregulates tumour necrosis factor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood 90:4162–4171PubMed Dickensheets H, Freeman SL, Smith M et al (1997) Interleukin 10 upregulates tumour necrosis factor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood 90:4162–4171PubMed
11.
go back to reference Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315–329CrossRefPubMed Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315–329CrossRefPubMed
12.
go back to reference Westendorp RG, Langermans JA, Huizinga TW et al (1997) Genetic influence on cytokine production and fatal meningococcal disease (published erratum appears in Lancet 1997;349:656) (see comments). Lancet 349:170–173 Westendorp RG, Langermans JA, Huizinga TW et al (1997) Genetic influence on cytokine production and fatal meningococcal disease (published erratum appears in Lancet 1997;349:656) (see comments). Lancet 349:170–173
13.
go back to reference D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150–154PubMed D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150–154PubMed
14.
go back to reference Higuchi T, Seki N, Kamizono S et al (1998) Polymorphism of the 5′-flanking region of the human tumour necrosis factor(TNF)-alpha gene in Japanese. Tissue Antigens 51:605–612CrossRefPubMed Higuchi T, Seki N, Kamizono S et al (1998) Polymorphism of the 5′-flanking region of the human tumour necrosis factor(TNF)-alpha gene in Japanese. Tissue Antigens 51:605–612CrossRefPubMed
15.
go back to reference Uglialoro AM, Turbay D, Pesavento PA et al (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52:359–367CrossRefPubMed Uglialoro AM, Turbay D, Pesavento PA et al (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52:359–367CrossRefPubMed
16.
go back to reference Brinkman BM, Giphart MJ, Verhoef A et al (1994) Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felty’s syndrome. Hum Immunol 41:259–266CrossRefPubMed Brinkman BM, Giphart MJ, Verhoef A et al (1994) Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felty’s syndrome. Hum Immunol 41:259–266CrossRefPubMed
17.
go back to reference Wilson AG, di Giovine FS, Blakemore AI (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353CrossRefPubMed Wilson AG, di Giovine FS, Blakemore AI (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353CrossRefPubMed
18.
go back to reference Brinkman BM, Kaijzel EL, Huizinga TW et al (1995) Detection of a C insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 96:493CrossRefPubMed Brinkman BM, Kaijzel EL, Huizinga TW et al (1995) Detection of a C insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 96:493CrossRefPubMed
19.
go back to reference Hamann A, Mantzoros C, Vidal-Puig A et al (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833–839CrossRefPubMed Hamann A, Mantzoros C, Vidal-Puig A et al (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833–839CrossRefPubMed
20.
go back to reference Gibson AW, Edberg JC, Wu J et al (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affects IL-10 production and enhance the risk of systemic lupus erythmatosus. J Immunol 166:3915–3922PubMed Gibson AW, Edberg JC, Wu J et al (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affects IL-10 production and enhance the risk of systemic lupus erythmatosus. J Immunol 166:3915–3922PubMed
21.
go back to reference Lee YH, Ji JD, Song GG (2007) Tumour necrosis factor-α promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34:43–49PubMed Lee YH, Ji JD, Song GG (2007) Tumour necrosis factor-α promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34:43–49PubMed
22.
go back to reference Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B et al (2002) Susceptibility and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β IR-1Ra genes. J Rheumatol 29:212–219PubMed Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B et al (2002) Susceptibility and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β IR-1Ra genes. J Rheumatol 29:212–219PubMed
23.
go back to reference Hajeer AH, Lazarus M, Turner D et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145CrossRefPubMed Hajeer AH, Lazarus M, Turner D et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145CrossRefPubMed
24.
go back to reference Huizinga TWJ, Keijsers V, Yanni G et al (2000) Are differences in interleukin 10 production associated with joint damage? Rheumatology 39:1180–1188CrossRefPubMed Huizinga TWJ, Keijsers V, Yanni G et al (2000) Are differences in interleukin 10 production associated with joint damage? Rheumatology 39:1180–1188CrossRefPubMed
25.
go back to reference Anand SP, Selvaraj P, Jawahar MS et al (2007) Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. Indian J Med Res 126:135–138 Anand SP, Selvaraj P, Jawahar MS et al (2007) Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. Indian J Med Res 126:135–138
26.
go back to reference Tegoshi H, Hasegawa G, Obayashi H et al (2002) Polymorphisms of interferon- γgene CA-repeat and interleukin-10 promoter region (−592A/C) in Japanese type 1 diabetes. Hum Immunol 63:121–128CrossRefPubMed Tegoshi H, Hasegawa G, Obayashi H et al (2002) Polymorphisms of interferon- γgene CA-repeat and interleukin-10 promoter region (−592A/C) in Japanese type 1 diabetes. Hum Immunol 63:121–128CrossRefPubMed
27.
go back to reference Sinha S, Mishra SK, Sharma S et al (2008) Polymorphisms of TNF-enhancer and gene for FcγRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 7:13CrossRefPubMed Sinha S, Mishra SK, Sharma S et al (2008) Polymorphisms of TNF-enhancer and gene for FcγRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 7:13CrossRefPubMed
28.
go back to reference Perrey C, Turner S, Pravica V et al (1999) ARMS-PCR methodologies to determine IL-10, TNFα and TGF-1 gene polymorphisms. Transpl Immunol 7:127–128CrossRefPubMed Perrey C, Turner S, Pravica V et al (1999) ARMS-PCR methodologies to determine IL-10, TNFα and TGF-1 gene polymorphisms. Transpl Immunol 7:127–128CrossRefPubMed
29.
go back to reference Coakley G, Mok CC, Hajeer AH et al (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37(9):988–991CrossRefPubMed Coakley G, Mok CC, Hajeer AH et al (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37(9):988–991CrossRefPubMed
30.
go back to reference Skoog T, van’t Hooft FM, Kallin B et al (1999) A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF- α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8:1443–1449CrossRefPubMed Skoog T, van’t Hooft FM, Kallin B et al (1999) A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF- α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8:1443–1449CrossRefPubMed
31.
go back to reference Mok CC, Lanchbury JS, Wai Chan D et al (1998) Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed Mok CC, Lanchbury JS, Wai Chan D et al (1998) Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed
32.
go back to reference Van Gestel AM, Haagsma CJ, Van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850CrossRefPubMed Van Gestel AM, Haagsma CJ, Van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850CrossRefPubMed
33.
go back to reference Fonseca EJ, Cavaleiro J, Teles J et al (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumour necrosis factor-alpha gene promoter. Arthritis Res Ther 9:R37CrossRefPubMed Fonseca EJ, Cavaleiro J, Teles J et al (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumour necrosis factor-alpha gene promoter. Arthritis Res Ther 9:R37CrossRefPubMed
34.
go back to reference Sharma S, Sharma A, Kumar S et al (2006) Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-α levels. Am J Respir Cell Mol Biol 35:488–495CrossRefPubMed Sharma S, Sharma A, Kumar S et al (2006) Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-α levels. Am J Respir Cell Mol Biol 35:488–495CrossRefPubMed
35.
go back to reference Brinkman BM, Huizinga TW, Kurban SS et al (1997) Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516–521CrossRefPubMed Brinkman BM, Huizinga TW, Kurban SS et al (1997) Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516–521CrossRefPubMed
36.
go back to reference Seki N, Kamizono S, Yamada A et al (1999) Polymorphisms in the 5′-flanking region of tumour necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197CrossRefPubMed Seki N, Kamizono S, Yamada A et al (1999) Polymorphisms in the 5′-flanking region of tumour necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197CrossRefPubMed
37.
go back to reference Yen JH, Chen CJ, Tsai WC et al (2001) Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 28:1788–1792PubMed Yen JH, Chen CJ, Tsai WC et al (2001) Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 28:1788–1792PubMed
38.
go back to reference Maury CP, Liljeström M, Laiho K et al (2003) Tumor necrosis factor α, its soluble receptor I and −308 gene promoter polymorphism in patient with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48:3068–3076CrossRefPubMed Maury CP, Liljeström M, Laiho K et al (2003) Tumor necrosis factor α, its soluble receptor I and −308 gene promoter polymorphism in patient with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48:3068–3076CrossRefPubMed
39.
go back to reference Jaini R, Kaur G, Mehra NK (2002) Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 63(1):24–29CrossRefPubMed Jaini R, Kaur G, Mehra NK (2002) Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 63(1):24–29CrossRefPubMed
40.
go back to reference Agrawal C, Raghav SK, Gupta B et al (2005) Tumour necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch Med Res 36:555–559CrossRefPubMed Agrawal C, Raghav SK, Gupta B et al (2005) Tumour necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch Med Res 36:555–559CrossRefPubMed
41.
go back to reference Okamoto K, Makino S, Yoshikawa Y et al (2003) Identification of I kappa BL as the second major histocompatibility complex linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 72:303–312CrossRefPubMed Okamoto K, Makino S, Yoshikawa Y et al (2003) Identification of I kappa BL as the second major histocompatibility complex linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 72:303–312CrossRefPubMed
42.
go back to reference Harney SMJ, Vilarino-Guell C, Adamopoulos IE et al (2008) Fine mapping of the MHC class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology 47:1761–1767CrossRefPubMed Harney SMJ, Vilarino-Guell C, Adamopoulos IE et al (2008) Fine mapping of the MHC class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology 47:1761–1767CrossRefPubMed
43.
go back to reference Hee CS, Gun SC, Naidu R et al (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 17(5):429–435CrossRefPubMed Hee CS, Gun SC, Naidu R et al (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 17(5):429–435CrossRefPubMed
44.
go back to reference Moreno OM, González CI, Saaibi DL et al (2007) Polymorphisms of IL-10 gene promoter and rheumatoid arthritis in a Colombian population. Biomedica 27:56–65PubMed Moreno OM, González CI, Saaibi DL et al (2007) Polymorphisms of IL-10 gene promoter and rheumatoid arthritis in a Colombian population. Biomedica 27:56–65PubMed
45.
go back to reference Ushiyama T, Mori K, Inoue K et al (1999) Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis. Ann Rheum Dis 58:57CrossRef Ushiyama T, Mori K, Inoue K et al (1999) Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis. Ann Rheum Dis 58:57CrossRef
46.
go back to reference Goemaere S, Ackerman C, Goethals K et al (1990) Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 17(12):1620–1622PubMed Goemaere S, Ackerman C, Goethals K et al (1990) Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 17(12):1620–1622PubMed
47.
go back to reference Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to onset of rheumatoid arthritis. Arthritis Rheum 35(2):152–155CrossRefPubMed Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to onset of rheumatoid arthritis. Arthritis Rheum 35(2):152–155CrossRefPubMed
48.
go back to reference Scola L, Crivello A, Marino V et al (2003) IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 124(4):569–572CrossRefPubMed Scola L, Crivello A, Marino V et al (2003) IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 124(4):569–572CrossRefPubMed
49.
go back to reference Udalova IA, Richardson A, Denys A et al (2000) Functional consequences of polymorphisms affecting NF-kappaB p50–50 binding to the TNF promoter region. Mol Cell Biol 2000(20):9113–9119CrossRef Udalova IA, Richardson A, Denys A et al (2000) Functional consequences of polymorphisms affecting NF-kappaB p50–50 binding to the TNF promoter region. Mol Cell Biol 2000(20):9113–9119CrossRef
Metadata
Title
Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population
Authors
Deepali Gambhir
Able Lawrence
Amita Aggarwal
Ramnath Misra
Sudhir Kumar Mandal
Sita Naik
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1131-0

Other articles of this Issue 9/2010

Rheumatology International 9/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine